Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | CDK9 | P50750 | 1/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6197081 | 0.77 | RAB9A (0.49) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL11199465 | 0.74 | SMN1; SMN2 (0.52) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL961819 | 0.74 | CYP1A2 (0.40) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL10900067 | 0.73 | MEN1 (0.57) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL27519753 | 0.70 | SMN1; SMN2 (0.56) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL27872143 | 0.70 | EPHX2 (0.42) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL677537 | 0.70 | KMT2A (0.54) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL2244779 | 0.69 | SMN1; SMN2 (0.61) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL8827353 | 0.69 | SMN1; SMN2 (0.61) | SMN1; SMN2RAB9ANPC1TSHRMEN1 | |
| SCHEMBL11321069 | 0.69 | NPC1 (0.62) | SMN1; SMN2RAB9ANPC1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113301802-B | Synergistic preservative compositions, methods of making and methods of use thereof | ISP投资有限公司 | 2023-08-25 | — | — | CN | claimed |
| US-20230240953-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2023-08-03 | — | — | US | claimed |
| EP-4171531-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2023-05-03 | — | — | EP | claimed |
| CN-107613767-B | Synergistic preservative composition | ISP投资有限公司 | 2022-06-21 | — | — | CN | claimed |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-02-03 | — | — | US | claimed |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ISP INVESTMENTS LLC (US) | 2022-01-18 | — | — | US | claimed |
| WO-2022005930-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-01-06 | — | — | WO | claimed |
| CN-107613954-B | Synergistic compositions of dehydroacetic acid and methods of reducing yellowing in various end-use compositions | ISP投资有限公司 | 2021-10-19 | — | — | CN | claimed |
| EP-3886582-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-10-06 | — | — | EP | claimed |
| CN-113301802-A | Synergistic preservative compositions, methods of making and methods of using the same | ISP投资有限公司 | 2021-08-24 | — | — | CN | claimed |
| US-20130195947-A1 | BIOCIDE POWDER FORMULATION | TROY TECHNOLOGY II, INC. | 2013-08-01 | — | — | US | claimed |
| EP-2547208-A1 | BIOCIDE POWDER FORMULATION | Isp Investments Inc. (US) | 2013-01-23 | — | — | EP | claimed |
| US-20120071522-A1 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES | ISP INVESTMENTS INC. (US) | 2012-03-22 | — | — | US | claimed |
| WO-2012024097-A1 | THERMO-STABLE, ARSENIC-FREE SYNERGISTIC BIOCIDE CONCENTRATE COMPOSITION FOR POLYMER MATRICES AND PROCESS FOR PREPARING SAME | ISP INVESTMENTS INC. (US) | 2012-02-23 | — | — | WO | claimed |
| WO-2011116168-A1 | BIOCIDE POWER FORMULATION | ISP INVESTMENTS INC. (US) | 2011-09-22 | — | — | WO | claimed |
| US-7951852-B2 | Mixing a microbiocide such as iodopropynyl butyl carbamate with a dry lubricant such as calcium stearate or zinc stearate to form a free-flowing powder additive for polymer, plastic, or polymer-wood composites | ISP INVESTMENTS INC. (US) | 2011-05-31 | — | — | US | claimed |
| US-20060229381-A1 | Free-flowing composition of a biocide and a processing additive therewith for incorporation into a polymer or plastic matrix product | ISP INVESTMENTS INC. | 2006-10-12 | — | — | US | claimed |
| WO-2006019517-A2 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES | ISP INVESTMENTS INC. (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060013833-A1 | Thermal stabilization of biocides in matrix compositions processed at elevated temperatures | ISP INVESTMENTS INC. | 2006-01-19 | — | — | US | claimed |
| US-20060013847-A1 | Thermal stabilization of IPBC biocide | ISP INVESTMENTS INC. | 2006-01-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240953-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | MPO, SPOUT1, ARG1 | SMN1; SMN2 3861/4885RAB9A 1895/4885NPC1 894/4885 |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | HPD, EBP, TET1 | SMN1; SMN2 3656/4885RAB9A 4741/4885NPC1 3614/4885 |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ALAD, SCD, DHCR7 | SMN1; SMN2 3041/4885RAB9A 3330/4885NPC1 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.